Medlab Clinical - Edison Group

Overview
Research
Sector insights
Thematics

Latest Insights

View More

Healthcare |
Outlook

23.01.23

Medlab Clinical — NanaBis development centre stage in 2023

Healthcare |
Flash note

17.01.23

Medlab Clinical — Encouraging real-world data to support NanaBis

Healthcare |
Flash note

04.01.23

Medlab Clinical — Moving closer to the Nasdaq IPO

Healthcare |
Flash note

12.12.22

Medlab Clinical — Progressing on multiple fronts

Test tube with DNA

Sector

Healthcare

Research

Update

Healthcare

14.07.22

Medlab Clinical — NanaBis – now with synthetic CBD and THC

edison tv

Healthcare

09.02.22

Medlab Clinical: Edison Open House Healthcare 2022

Healthcare

Flash note

Medlab Clinical — FY22 cash flows within our expectations

Update

Healthcare

27.01.22

Medlab Clinical — Transforming into a pure-play biotech

edison tv

Healthcare

28.07.21

Medlab Clinical – executive interview

Initiation

Healthcare

12.07.21

Medlab Clinical — Novel drug delivery and cannabinoids against pain

QuickView

Healthcare

01.06.21

Medlab Clinical — Novel drug delivery and synthetic cannabinoids

Further insights

insight

Healthcare

09.12.22

Healthcare Week 2023

insight

Healthcare

15.02.22

Medlab Clinical: A new focus on patient suffering

thematic

Healthcare

13.06.23

ASCO 2023 key takeaways

thematic

Healthcare

26.01.23

Machine learning in drug development

thematic

Healthcare

06.01.23

Outlook for 2023: Biotechs remain central to novel drug development

Cancer cells

thematic

Healthcare

04.01.23

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

cell DNA double helix

thematic

Healthcare

20.12.22

Cell and gene therapies

thematic

Healthcare

28.11.22

Drug delivery platforms

thematic

Healthcare

07.11.22

Oncology ABCs (part three) – thinking outside the box in women’s cancer

thematic

Healthcare

01.11.22

Neuroscience comeback

thematic

Consumer

05.10.22

IPO apocalypse

thematic

Healthcare

03.10.22

Oncology ABCs (part two) – vaccines: niche no longer

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Healthcare

01.07.22

Oncology ABCs (part one) – a small-cap biopharma prospectus series

thematic

Healthcare

26.04.22

Cannabinoid manufacturing – Innovative approaches to the production of cannabinoids

thematic

Healthcare

10.11.21

Artificial intelligence in drug discovery

thematic

Healthcare

27.07.21

Biosynthesis – Taking the cannabinoid market to new heights

thematic

Healthcare

22.03.21

Seven things every investor should know about SIGA technologies & biological weapons

thematic

Healthcare

01.02.21

Confidence renewed as new COVID-19 vaccines demonstrate protection against emergent strains and efficacy with a single-dose regimen

thematic

Healthcare

30.10.19

Edison Exhibits- antibiotic development

thematic

Healthcare

17.07.19

The next wave in AMD

thematic

Healthcare

18.06.19

The A-B-T of biosimilars- Explaining contemporary life science issues

thematic

Healthcare

10.06.19

Cannabinoid Therapies- The coming retail wave

thematic

Healthcare

22.05.19

Cannabinoid Therapies- Therapeutics turning a corner

thematic

Healthcare

08.04.19

Trial outcomes and value – Explaining contemporary clinical trial issues

thematic

Healthcare

04.03.19

Drug pricing – Market access and reimbursement

thematic

Healthcare

29.01.19

The diagnostics sector

thematic

Healthcare

21.06.17

ASCO 2017

thematic

Consumer

11.11.14

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Healthcare

05.03.14

Edison healthcare quarterly: A boost for allergy immunotherapy

thematic

Energy & Resources

04.03.14

ASX Spotlight Conference – London, 6 March 2014

thematic

Energy & Resources

01.03.13

ASX Small to Mid Caps Conference – London, 7 March 2013

thematic

Healthcare

07.12.12

Edison healthcare quarterly: Boom times for US biotech

thematic

Healthcare

30.08.12

Edison healthcare quarterly: Crisis? What crisis?

thematic

Healthcare

28.05.12

Edison healthcare quarterly: How to please some of the people some of the time